Palma, Catarina
David, Cláudio
Fernandes, Ricardo M.
Pinto, Fausto J.
Costa, João
Ferreira, Joaquim J.
Caldeira, Daniel
Article History
Received: 3 March 2022
Accepted: 4 May 2022
First Online: 14 May 2022
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
: DC has participated in educational meetings and/or attended conferences or symposia (including travel, accommodation, and/or hospitality) with Bristol-Myers Squibb, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Merck Serono, Ferrer, Pfizer, Novartis, and Roche > 3 years; no conflicts of interest < 3 years. JJF had speaker and consultant fees with Grünenthal, Fundação MSD (Portugal), TEVA, MSD, Allergan, Medtronic, GlaxoSmithKline, Novartis, Lundbeck, Solvay, BIAL, Merck Serono, Merz, Ipsen, Biogen, Acadia, Allergan, Abbvie, Sunovion-Pharmaceuticals. FJP had consultant and speaker fees with Astra Zeneca, Bayer, BMS, Boehringer Ingelheim and Daiichi Sankyo. There is no any other conflict of interest by the rest of the authors.